Literature DB >> 24671702

Electrophysiological aberrations associated with negative symptoms in schizophrenia.

Nash N Boutros1, Armida Mucci, Annarita Vignapiano, Silvana Galderisi.   

Abstract

Clinical heterogeneity is a confound common to all of schizophrenia research. Deficit schizophrenia has been proposed as a homogeneous disease entity within the schizophrenia syndrome. The use of the Schedule for the Deficit Syndrome (SDS) has allowed the definition of a subgroup dominated by persistent and primary negative symptoms. While a number of studies have appeared over the years examining the electrophysiological correlates of the cluster of negative symptoms in schizophrenia, only a few studies have actually focused on the Deficit Syndrome (DS). In this chapter, electrophysiological investigations utilizing EEG, Evoked Potentials (EPs), polysomnography (PSG), or magnetoencephalography (MEG) to probe "negative symptoms," or "Deficit Syndrome" are reviewed. While this line of research is evidently in its infancy, two significant trends emerge. First, spectral EEG studies link increased slow wave activity during wakefulness to the prevalence of negative symptoms. Second, sleep studies point to an association between decrease in slow wave sleep and prevalence of negative symptoms. Several studies also indicate a relationship of negative symptoms with reduced alpha activity. A host of other abnormalities including sensory gating and P300 attenuation are less consistently reported. Three studies specifically addressed electrophysiology of the DS. Two of the three studies provided evidence suggesting that the DS may be a separate disease entity and not simply a severe form of schizophrenia.

Entities:  

Year:  2014        PMID: 24671702     DOI: 10.1007/7854_2014_303

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  6 in total

1.  Sleep in patients with schizophrenia.

Authors:  Fabio Ferrarelli
Journal:  Curr Sleep Med Rep       Date:  2015-04-11

Review 2.  Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis.

Authors:  Andrew M Rosen; Timothy Spellman; Joshua A Gordon
Journal:  Biol Psychiatry       Date:  2015-03-27       Impact factor: 13.382

3.  State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effects.

Authors:  Robert W Gould; Michael T Nedelcovych; Xuewen Gong; Erica Tsai; Michael Bubser; Thomas M Bridges; Michael R Wood; Mark E Duggan; Nicholas J Brandon; John Dunlop; Michael W Wood; Magnus Ivarsson; Meredith J Noetzel; J Scott Daniels; Colleen M Niswender; Craig W Lindsley; P Jeffrey Conn; Carrie K Jones
Journal:  Neuropharmacology       Date:  2015-11-23       Impact factor: 5.250

4.  Event-related potentials demonstrate deficits in acoustic segmentation in schizophrenia.

Authors:  Brian A Coffman; Sarah M Haigh; Tim K Murphy; Dean F Salisbury
Journal:  Schizophr Res       Date:  2016-03-28       Impact factor: 4.939

5.  Effects of Ketamine on Resting-State EEG Activity and Their Relationship to Perceptual/Dissociative Symptoms in Healthy Humans.

Authors:  Sara de la Salle; Joelle Choueiry; Dhrasti Shah; Hayley Bowers; Judy McIntosh; Vadim Ilivitsky; Verner Knott
Journal:  Front Pharmacol       Date:  2016-09-27       Impact factor: 5.810

6.  Levels of attention and task difficulty in the modulation of interval duration mismatch negativity.

Authors:  Alana M Campbell; Deana B Davalos
Journal:  Front Psychol       Date:  2015-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.